PRODROMAL ALZHEIMER'S DISEASE
Clinical trials for PRODROMAL ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new PRODROMAL ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for PRODROMAL ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine combo aims to slow Alzheimer's by targeting tau tangles
Disease control ENROLLING_BY_INVITATIONThis study tests a vaccine called AADvac1, which targets tau tangles in the brain, a hallmark of Alzheimer's. It will be given alone or with another drug (donanemab) to 450 adults aged 50-80 with very early Alzheimer's. The goal is to see if this approach can reduce tau buildup a…
Matched conditions: PRODROMAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Digital memory notebook aims to boost daily life for seniors with mild cognitive issues
Symptom relief ENROLLING_BY_INVITATIONThis study tests a tablet-based app called the Digital Memory Notebook (DMN) to help older adults with mild memory problems or early Alzheimer's manage everyday tasks like appointments and medications. Twenty participants will learn to use the app over six weekly sessions, then c…
Matched conditions: PRODROMAL ALZHEIMER'S DISEASE
Phase: NA • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC